TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -20.35%12.46B | -0.47%40.93B | -16.35%15.64B | 35.71%41.13B | 32.85%18.7B | -3.12%30.31B | 8.35%14.07B | -21.69%31.28B | -25.75%12.99B | 71.92%39.94B |
Operating income | -20.35%12.46B | -0.47%40.93B | -16.35%15.64B | 35.71%41.13B | 32.85%18.7B | -3.12%30.31B | 8.35%14.07B | -21.69%31.28B | -25.75%12.99B | 71.92%39.94B |
Cost of sales | 8.70%-10.68B | -8.41%-32.57B | 12.73%-11.7B | -49.90%-30.05B | -53.49%-13.41B | 3.29%-20.04B | -7.72%-8.73B | 21.52%-20.73B | 19.51%-8.11B | -79.47%-26.41B |
Operating expenses | 8.70%-10.68B | -8.41%-32.57B | 12.73%-11.7B | -49.90%-30.05B | -53.49%-13.41B | 3.29%-20.04B | -7.72%-8.73B | 21.52%-20.73B | 19.51%-8.11B | -79.47%-26.41B |
Gross profit | -54.93%1.78B | -24.55%8.36B | -25.53%3.94B | 7.99%11.08B | -0.92%5.29B | -2.78%10.26B | 9.41%5.34B | -22.02%10.55B | -34.22%4.88B | 58.88%13.53B |
Selling expenses | 18.91%-431.37M | -7.89%-1.32B | -17.44%-531.96M | -8.23%-1.23B | 12.60%-452.95M | -18.42%-1.13B | -84.53%-518.23M | 19.93%-957.61M | 47.90%-280.84M | -72.59%-1.2B |
Administrative expenses | 18.34%-442.44M | -0.17%-1.27B | -12.04%-541.83M | 10.13%-1.27B | 21.40%-483.59M | 17.22%-1.41B | -17.99%-615.24M | 11.40%-1.7B | 18.79%-521.44M | -19.62%-1.92B |
Profit from asset sales | ---- | ---- | ---1.03M | ---- | ---- | --269.9M | 221.21%321.31M | ---- | ---265.08M | ---- |
Revaluation surplus | -103.70%-1.43M | -47.35%-180.91M | 185.07%38.57M | -299.46%-122.77M | -51.82%13.53M | 140.36%61.55M | 122.38%28.08M | -426.52%-152.5M | -300.74%-125.48M | -84.08%46.7M |
-Changes in the fair value of investment property | ---34.46M | -48.42%-250.16M | ---- | -29,679.15%-168.55M | ---23M | 99.77%-566K | ---- | -2,965.51%-243.19M | -519.01%-142.85M | -102.84%-7.93M |
-Changes in the fair value of financial assets | -14.36%33.03M | 51.27%69.25M | 5.58%38.57M | -26.30%45.78M | 30.08%36.53M | -31.51%62.12M | 61.71%28.08M | 65.99%90.69M | -38.89%17.37M | 279.71%54.64M |
Impairment and provision | ---- | 81.36%-101.29M | ---- | -166.01%-543.26M | ---46.79M | -416.71%-204.23M | ---- | 96.13%-39.52M | ---- | -9,252.65%-1.02B |
-Impairment of property, machinery and equipment | ---- | 81.36%-101.29M | ---- | -166.01%-543.26M | ---46.79M | -416.71%-204.23M | ---- | 96.13%-39.52M | ---- | -9,252.65%-1.02B |
Operating interest expense | ---- | ---- | ---- | ---- | 11.56%-730.1M | 17.31%-1.54B | -5.52%-825.58M | -26.00%-1.86B | ---782.36M | ---1.47B |
Special items of operating profit | 1,539.39%282.39M | 151.73%232.17M | 92.72%-19.62M | -271.64%-448.83M | -186.93%-269.35M | -66.69%261.49M | 102.38%309.83M | 223.49%785M | 2,170.00%153.09M | 8,673.28%242.67M |
Operating profit | -58.98%1.18B | -23.48%5.72B | -13.17%2.88B | 13.71%7.47B | -17.79%3.32B | -0.90%6.57B | 32.09%4.04B | -19.26%6.63B | -51.51%3.06B | 26.26%8.21B |
Financing cost | 13.64%-707.43M | 0.73%-1.59B | ---819.18M | ---1.61B | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | 133.62%98.28M | -714.98%-70.74M | 157.39%42.07M | -115.35%-8.68M | -261.18%-73.31M | 307.80%56.56M | 270.50%45.48M | -31.94%-27.22M | -11.44%-26.68M | 61.76%-20.63M |
Share of profit from joint venture company | 159.03%5.44M | 7.39%-21.13M | 56.36%-9.21M | -131.69%-22.82M | -109.99%-21.1M | -61.17%72M | 667.79%211.24M | -62.80%185.4M | -89.38%27.51M | 99.04%498.34M |
Earning before tax | -72.38%579.36M | -30.90%4.03B | -34.99%2.1B | -12.90%5.84B | -24.90%3.23B | -1.32%6.7B | 40.44%4.3B | -21.88%6.79B | -47.27%3.06B | 60.18%8.69B |
Tax | 76.02%-330.72M | 50.27%-2.4B | 30.96%-1.38B | -6.40%-4.83B | 21.32%-2B | -1.61%-4.54B | -33.22%-2.54B | 8.91%-4.46B | -6.63%-1.91B | -73.58%-4.9B |
After-tax profit from continuing operations | -65.42%248.64M | 61.68%1.63B | -41.54%719.01M | -53.35%1.01B | -30.06%1.23B | -6.93%2.16B | 52.35%1.76B | -38.64%2.32B | -71.25%1.15B | 45.64%3.79B |
Earning after tax | -65.42%248.64M | 61.68%1.63B | -41.54%719.01M | -53.35%1.01B | -30.06%1.23B | -6.93%2.16B | 52.35%1.76B | -38.64%2.32B | -71.25%1.15B | 45.64%3.79B |
Minority profit | -256.14%-124.59M | -3.05%187.28M | 306.21%79.79M | 84.95%193.18M | -140.55%-38.7M | -76.50%104.45M | -70.72%95.43M | 1,103.01%444.53M | 17.36%325.89M | -112.32%-44.32M |
Profit attributable to shareholders | -41.61%373.23M | 77.01%1.44B | -49.61%639.21M | -60.36%816.15M | -23.73%1.27B | 9.52%2.06B | 100.77%1.66B | -50.95%1.88B | -77.84%828.4M | 70.99%3.83B |
Basic earnings per share | -41.60%0.0977 | 74.16%0.3781 | -51.02%0.1673 | -61.16%0.2171 | -24.79%0.3416 | 8.86%0.559 | 100.80%0.4542 | -50.95%0.5135 | -77.84%0.2262 | 70.99%1.0468 |
Diluted earnings per share | -41.60%0.0977 | 74.16%0.3781 | -51.02%0.1673 | -61.16%0.2171 | -24.79%0.3416 | 8.97%0.559 | 100.80%0.4542 | -50.82%0.513 | -77.75%0.2262 | 70.39%1.0431 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.